What's new

Human medicines European public assessment report (EPAR): Pemetrexed Fresenius Kabi, pemetrexed, Date of authorisation: 22/07/2016, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR): Pemetrexed Fresenius Kabi, pemetrexed, Date of authorisation: 22/07/2016, Revision: 15, Status: Authorised

Feb 12, 2025 - 10:30
 0
Human medicines European public assessment report (EPAR): Pemetrexed Fresenius Kabi, pemetrexed, Date of authorisation: 22/07/2016, Revision: 15, Status: Authorised
Human medicines European public assessment report (EPAR): Pemetrexed Fresenius Kabi, pemetrexed, Date of authorisation: 22/07/2016, Revision: 15, Status: Authorised
Read More

Tags:

Previous Article

Opinion: Gilead’s short-term win threatens the future of pharmaceutical public-p...

Next Article

Human medicines European public assessment report (EPAR): Emblaveo, aztreonam,av...

Related Posts

Human medicines European public assessment report (EPAR): Biktarvy, bictegravir,emtricitabine,tenofovir alafenamide, Date of authorisation: 21/06/2018, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 27, 2025  0

Human medicines European public assessment report (EPAR): Urorec, silodosin, Date of authorisation: 29/01/2010, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0

Minutes - PDCO minutes of the 10-13 December 2024 meeting

Feb 13, 2025  0